Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nanosphere Inc (NASDAQ:NSPH)

2.62
Delayed Data
As of Aug 28
 +0.15 / +6.07%
Today’s Change
2.06
Today|||52-Week Range
25.40
-66.59%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$19.3M

Company Description

Nanosphere, Inc. develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene System, that enables simple, low cost and highly sensitive genomic and protein testing on a single platform. The Verigene System includes a bench-top molecular diagnostics workstation that is a universal platform for genomic and protein testing and provides for multiple tests to be performed on a single platform, including both genomic and protein assays, from a single sample. Its proprietary nanoparticle technology provides the ability to run multiple tests simultaneously on the same sample. Nanosphere was founded by Chad A. Mirkin and Robert Letsinger on December 30, 1999 and is headquartered in Northbrook, IL.

Contact Information

Nanosphere, Inc.
4088 Commercial Avenue
Northbrook Illinois 60062
P:(847) 400-9000
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Michael K. McGarrityPresident, Chief Executive Officer & Director
Farzana MoinuddinChief Financial & Accounting Officer
Kenneth D. BahkChief Strategy Officer
Crowther ZacharyMarketing Director & Head-Media Contact